Drug utilization of paliperidone in adolescent schizophrenia patients: A retrospective cohort study in China

INTRODUCTION: In China, the indications of paliperidone extended in schizophrenia adolescents (12-17 years) was approved by National Medical Products Administration (NMPA) in 2017. But, the utilization of paliperidone in this group needs to be further investigated. OBJECTIVES: To assess paliperidone...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, S., Zhang, T., Wu, T., Zhang, L., Sun, H., Dong, W., Wang, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476006/
http://dx.doi.org/10.1192/j.eurpsy.2021.1368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476006/
http://dx.doi.org/10.1192/j.eurpsy.2021.1368

Ejemplares similares